ID
39898
Beschrijving
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the Cystic fibrosis exacerbations form. It has to be filled in if the subject has a cystic fibrosis exacerbation during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Trefwoorden
Versies (2)
- 25-02-20 25-02-20 -
- 02-03-20 02-03-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
2 maart 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Cystic fibrosis exacerbations
- StudyEvent: ODM
Beschrijving
Cystic fibrosis exacerbations
Alias
- UMLS CUI-1
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI-2
- C4086268 (Exacerbation)
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1,1]
- C0574845 (Date of onset)
- SNOMED
- 298059007
- LOINC
- MTHU048807
- UMLS CUI [1,2]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,3]
- C4086268 (Exacerbation)
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1,1]
- C0449244 (Time of onset)
- SNOMED
- 263501003
- UMLS CUI [1,2]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,3]
- C4086268 (Exacerbation)
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008 (Date in time)
- SNOMED
- 410671006
- UMLS CUI [1,2]
- C2699488 (Resolution)
- UMLS CUI [1,3]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,4]
- C4086268 (Exacerbation)
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1,1]
- C0040223 (Time)
- SNOMED
- 410670007
- LOINC
- LP73517-2
- UMLS CUI [1,2]
- C2699488 (Resolution)
- UMLS CUI [1,3]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,4]
- C4086268 (Exacerbation)
Beschrijving
Antibiotics prescription for exacerbation of CF
Datatype
text
Alias
- UMLS CUI [1,1]
- C0003232 (Antibiotics)
- SNOMED
- 255631004
- LOINC
- LP31426-7
- UMLS CUI [1,2]
- C0033080 (Prescription procedure)
- SNOMED
- 260885003
- UMLS CUI [1,3]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,4]
- C4086268 (Exacerbation)
Beschrijving
Hospitalisation of subject due to exacerbation of CF
Datatype
text
Alias
- UMLS CUI [1,1]
- C0019993 (Hospitalization)
- SNOMED
- 394656005
- LOINC
- LA15417-1
- UMLS CUI [1,2]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,3]
- C4086268 (Exacerbation)
Beschrijving
Withdrawal of subject due to exacerbation of CF
Datatype
text
Alias
- UMLS CUI [1,1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
- UMLS CUI [1,2]
- C0010674 (Cystic Fibrosis)
- SNOMED
- 190905008
- UMLS CUI [1,3]
- C4086268 (Exacerbation)
Similar models
Cystic fibrosis exacerbations
- StudyEvent: ODM
C4086268 (UMLS CUI-2)
C0010674 (UMLS CUI [1,2])
C4086268 (UMLS CUI [1,3])
C0010674 (UMLS CUI [1,2])
C4086268 (UMLS CUI [1,3])
C2699488 (UMLS CUI [1,2])
C0010674 (UMLS CUI [1,3])
C4086268 (UMLS CUI [1,4])
C2699488 (UMLS CUI [1,2])
C0010674 (UMLS CUI [1,3])
C4086268 (UMLS CUI [1,4])
C0033080 (UMLS CUI [1,2])
C0010674 (UMLS CUI [1,3])
C4086268 (UMLS CUI [1,4])
C0010674 (UMLS CUI [1,2])
C4086268 (UMLS CUI [1,3])
C0010674 (UMLS CUI [1,2])
C4086268 (UMLS CUI [1,3])
Geen commentaren